Vaccine (and Other Biologic) Manufacturing Services for Infectious Diseases
Past New Requirement Updated
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Solicitation expected
- Not on record
- Estimated value
- $1,500,000 to $3,000,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Points of contact
-
- Andy Cherry andy.cherry@nih.gov
- Lisa Wei lisa.wei@nih.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Department of Health and Human Services National Institutes of Health (NIH) is forecasting a new contract opportunity for Vaccine (and Other Biologic) Manufacturing Services for Infectious Diseases. This procurement is focused on research and development in biotechnology, specifically within NAICS code 541714, with an estimated award date of November 1, 2024. The contract aims to support critical vaccine and biologic manufacturing services for addressing infectious disease challenges.
While specific award values and precise service quantities are not detailed in the forecast, the opportunity involves biotechnology research and development services with key points of contact including Andy Cherry (andy.cherry@nih.gov) and Lisa Wei (lisa.wei@nih.gov), both from NIH's leadership. The procurement is not set aside for any specific category of business, suggesting open competition among qualified biotechnology and research organizations. Potential vendors should be prepared to demonstrate advanced capabilities in vaccine and biologic manufacturing research, with the work likely to be performed at NIH facilities or designated research locations.
Forecast text
Vaccine (and Other Biologic) Manufacturing Services for Infectious Diseases
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast